Enorama Pharma AB (publ) (STO:ERMA)
Sweden · Delayed Price · Currency is SEK 0.3300
0.00 (0.00%)
Jul 24, 2026, 11:50 AM CET
Enorama Pharma AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| -1.01 | -6.74 | 27.61 | 1.12 | 9.44 | 12.95 | |
Revenue Growth (YoY) | - | - | 2363.16% | -88.13% | -27.06% | 152.77% |
Cost of Revenue | 4.61 | 8.29 | 22.96 | 4.38 | 8.34 | 8.32 |
Gross Profit | -5.62 | -15.03 | 4.66 | -3.26 | 1.1 | 4.63 |
Selling, General & Admin | 49.9 | 46.61 | 31.13 | 34.39 | 37.83 | 29.99 |
Depreciation & Amortization Expenses | 0.42 | 0.47 | 20.41 | 3.55 | 3.54 | 1.38 |
Other Operating Expenses | 1.08 | 0.71 | 0.63 | 0.93 | 1.21 | 0.19 |
Total Operating Expenses | 51.39 | 47.78 | 52.17 | 38.87 | 42.57 | 31.57 |
Operating Income | -57.01 | -62.81 | -47.52 | -42.13 | -41.47 | -26.94 |
Interest Income | 1.83 | 0.32 | 6.7 | 1.1 | 1.53 | 0 |
Interest Expense | -10.09 | -12.65 | -2.99 | -3.59 | -2.09 | -0.8 |
Total Non-Operating Income (Expense) | -8.27 | -12.33 | 3.71 | -2.49 | -0.56 | -0.8 |
Pretax Income | -65.27 | -75.14 | -43.81 | -44.61 | -42.03 | -27.74 |
Net Income | -65.27 | -75.14 | -43.81 | -44.61 | -42.03 | -27.74 |
Net Income to Common | -65.27 | -75.14 | -43.81 | -44.61 | -42.03 | -27.74 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 73 | 69 | 53 | 28 | 8 | 6 |
Shares Outstanding (Diluted) | 73 | 69 | 53 | 28 | 8 | 6 |
Shares Change (YoY) | 26.13% | 30.99% | 91.50% | 253.96% | 26.23% | 11.44% |
EPS (Basic) | -0.91 | -1.01 | -0.72 | -1.09 | -4.49 | -3.61 |
EPS (Diluted) | -0.91 | -1.01 | -0.72 | -1.09 | -4.49 | -3.61 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -46.09 | -59.26 | -35.7 | -41.35 | -32.96 | -30.22 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.64 | -0.85 | -0.67 | -1.49 | -4.21 | -4.88 |
Gross Margin | 555.79% | 223.02% | 16.87% | -290.90% | 11.68% | 35.72% |
Operating Margin | 5638.87% | 932.18% | -172.08% | -3757.98% | -439.16% | -208.08% |
Profit Margin | 6456.28% | 1115.15% | -158.65% | -3979.75% | -445.09% | -214.27% |
FCF Margin | 4558.56% | 879.50% | -129.30% | -3688.58% | -349.02% | -233.44% |
EBITDA | -56.59 | -62.34 | -27.11 | -38.58 | -37.93 | -25.56 |
EBITDA Margin | 5597.82% | 925.22% | -98.16% | -3441.48% | -401.71% | -197.41% |
EBIT | -57.01 | -62.81 | -47.52 | -42.13 | -41.47 | -26.94 |
EBIT Margin | 5638.87% | 932.18% | -172.08% | -3757.98% | -439.16% | -208.08% |